ZHU Kai-mei, GU Sheng-jiu, LI Mei-bo, et al. Shikimic Acid Inducing Apoptosis on Hepatocellular Carcinoma HepG-2 Cells Through Decreasing the Ratio of Bcl-2/Bax[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 154-158.
ZHU Kai-mei, GU Sheng-jiu, LI Mei-bo, et al. Shikimic Acid Inducing Apoptosis on Hepatocellular Carcinoma HepG-2 Cells Through Decreasing the Ratio of Bcl-2/Bax[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(8): 154-158. DOI: 10.13422/j.cnki.syfix.2014080154.
Objective: To investigate the effects of shikimic acid on inducing hepatocellular carcinoma HepG-2 cells apoptosis in vitro. Method: The MTT assay was used
and the hepatocellular carcinoma HepG-2 cells in logarithmic phase of growth were randomly divided into control group and treatment group treated with the concentration of 0.125
0.5
1 g·L-1 shikimic acid in hepatocellular carcinoma HepG-2 cells. The cell cycle distribution was analyzed by flow cytometry. The protein expression of B cell lymphoma/leukemia-2(Bcl-2) and Bcl-2 associated x protein(Bax) was analyzed by immunocytochemical method. Result: Shikimic acid inhibited the growth of cells significantly(P<0.05). The suppression was both in a time-and dose-dependent manner. The flow cytometry showed that shikimic acid can inhibit the proliferation by preventing cells turning into S phase from G1 phase in cell cycle
at the same time
shikimic acid down-regulated the Bcl-2 expression and up-regulated the Bax expression
the ratio of Bcl-2/Bax was evident decrease. Conclusion: Shikimic acid can inhibit proliferation hepatocellular carcinoma HepG-2 cells and induce a G1 cell cycle arrest and reduce the cell population in S phase
it may induce apoptosis through decreasing the ratio of Bcl-2/Bax.